目的 调查医院真菌血流感染状况,为真菌血流感染的预防和治疗提供参考。方法 对某部队医院2013-2018年真菌血流感染的检测结果进行回顾性分析,对感染真菌种类、科室分布及耐药性状况进行分析。结果 共分离真菌血流感染菌株97株, 30.93%为白色念珠菌,但由2013年的41.67%,下降至2018年的27.78%,呈现下降趋势。真菌血流感染的主要科室为血液科(24.74%)和重症医学科(22.68%)。97株真菌对4种抗菌药物的敏感率:氟胞嘧啶97.80%、伏立康唑97.80%、氟康唑93.30%、伊曲康唑71.10%。结论 血流感染真菌以白色念珠菌为主,但非白色念珠菌感染有上升趋势;提高患者免疫力,减少有创性检查和治疗是减少真菌血流感染的重要环节;三唑类药是抗真菌药的主力军,在治疗过程中需要检测其耐药性的变化。
Abstract
Objective To investigate the current fungal blood stream infections and to provide reference for the prevention and treatment of fungemia.Methods Retrospective analysis was used to test the results of fungal blood stream infections in a military hospital between 2013 and 2018. The species, distribution and drug resistance were analyzed.Results 97 strains of fungal blood stream infections were isolated, mainly Candida albicans(30.93%), but the proportion decreased(from 41.76% in 2013 to 27.78% in 2018). Fungal blood stream infections occurred most often in departments of hematology(24.74%) and intensive care medicine (22.68%). The sensitivities to four antimicrobial agents were as follows: 5-fluorocytosine (97.80%), voriconazole (97.80%), fluconazole (93.30%), and itraconazole (71.10%).Conclusions Candida albicans is the main fungus associated with blood stream infections, but infections with non-Candida albicans are on the rise. Improving immunity and reducing invasive examination and treatment are important to reduce fungal blood flow in fection.Triazoles are still the mainstream antifungal drugs, and resistance needs to be tested in the course of treatment.
关键词
血流感染 /
真菌 /
真菌血流感染 /
分析
Key words
blood stream infection /
fungus /
fungemia /
analysis
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 黄小燕,赵喜荣,苏建忠,等.院内感染254例现状分析[J].武警医学,2018,29(1):71-72.
[2] Kullberg B J,Arendrup M C.Invasive candidiasis[J].N Engl J Med,2015,373(15):1445-1456.
[3] 张立娜,贺政新,安黎云,等.真菌血症患者血小板计数动态变化回顾分析[J].检验医学与临床,2015,12(3):312-316.
[4] 凌 勇,侯铁英,陈柳勤,等.250例真菌性血流感染的临床特点分析[J].中华医院感染学杂志,2016,26(21):4876-4881.
[5] 陈 玉,鲁俊锋,魏 兵,等.82例念珠菌血症患者的临床分析[J].中华实验和临床感染病杂志(电子版), 2017,11(4):373-376.
[6] Cornely O A, Gachot B, Akan H, et al. Epidemiology and outcome of fungemia in a cancer cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031) [J].Clin Infect Dis,2015,61(3):324-331.
[7] Peron I H,Reichert L F,Busso L A F,et al.Resistance surveillance in Candida albicans:a five-year antifungal susceptibility evaluation in a Bbrazilian University Hospital[J]. PLoS One,2016,11(7):e0158126.
[8] Eliakim R N,Babaoff R,Yahav D,et al.Epidemiology,microbiology,clinical characteristics,and outcomes of candidemia in internal medicine wards-a retrospective study[J].Int J Infect Dis,2016,52:49-54.
[9] Montagna M T,Caggiano G,Lovero G,et al.Epidemiology of invasive fungal infections in the intensive care unit:results of a multicenter Italian survey(AURORA Project)[J].Infection,2013,41(3):645-653.
[10] Guimaraes T,Nucci M, Mendonca J S,et al.Epidemiology and predictors of a poor outcome in elderly patients with candidemia[J].Int J Infect Dis,2012,16(6):e442-e447.
[11] 公衍文,李继霞,胡成进.侵袭性真菌感染可疑病原菌种分布及其耐药现状[J].国际检验医学杂志,2013,34(22):3003-3004.
[12] 宁永忠.2016 美国感染性疾病学会念珠菌病处置的临床实践指南解读[J]. 中华临床实验室管理电子杂志, 2016, 4(3):148-152.
[13] 李春年,吴小军.19284份血培养的真菌分布和临床特点分析[J].临床肺科杂志,2017,22(12):2175-2178.
[14] Calandra T,Roberts J A,Antonelli M,et al.Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy[J].Crit Care,2016,20(1):125.
[15] 符加红,赵 阳,栾 婷,等.ICU血行感染早期降钙素原变化幅度的比较[J].中国呼吸与危重监护杂志,2014,13(2):158-161.
[16] 黄道政,张佳佳,王首红,等.降钙素原在早期诊断高龄危重患者念珠菌败血症中的作用[J].广东医学,2013,34(7):1061-1063.
PDF(655 KB)
